Embryos with abnormal chromosomes (also called aneuploid embryos) normally result in a miscarriage or may lead to the birth of a child with genetic condition.
PGT-A is particularly important for female patients over age 35, as the risk of chromosomal abnormality increases with maternal age.
PGT-A (also known as PGS, Preimplantation Genetic Screening) is a genetic testing before embryo transfer to screen the embryo genetic health, so that your physician could select the best embryo for implantation and achieving a successful pregnancy.
Moreover, PGT-A can greatly reduce the chances of a patient having multiple pregnancies by providing information to select the optimal embryo for Single Embryo Transfer.
This test is recommended for people who:
- Women who are over the age of 35.
- Couples with infertility concerns.
- Couples with recurrent miscarriage.
- Couples with three of more failed IVF cycles.
- Couples with a family history of chromosomal abnormalities.
- Couples undergoing IVF treatment for other reasons.
PGT-A can also synchronize with MIRA to increase the pregnancy rate: Maximizing the successful chances of best embryo transfer at the right time!
Advantages of GGA PGT-A in Reproductive Medicine
Why Choose GGA PGT-A?